noninvasive modality for detection of myocardial ischemia and coronary artery disease. Magnetic resonance coronary angiography (MRCA) allows visualization of the coronary tree, but its incremental value as part of a CMR protocol including MPI and late gadolinium enhancement (LGE) is not well established. We aimed to evaluate the additive diagnostic value of a 3-dimensional whole-heart MRCA integration into a 1.5T CMR-MPI/LGE protocol for the detection of functionally significant coronary artery disease. Methods and Results-Forty-three symptomatic patients (61±8.3 years; 65% men) with suspected coronary artery disease and intermediate/high-pretest probability underwent CMR (including CMR-MPI, MRCA, and LGE) and x-ray invasive coronary angiography (XA) with fractional flow reserve evaluation. Diagnostic performances of MRCA, CMR-MPI/ LGE, and MRCA+CMR-MPI/LGE integration were determined having XA+fractional flow reserve as standard for coronary artery disease (≥90% stenosis/occlusion or fractional flow reserve≤0.80 in vessels>2 mm). MRCA inclusion into the CMR protocol was associated with a mean increase of 7.9±4.69 (0-17.7) minutes in total examination duration (14%). On patient-based analysis, MRCA had 96% sensitivity, 68% specificity, positive predictive value of 79%, and negative predictive value of 93%. CMR-MPI/LGE had 79% sensitivity, 95% specificity, positive predictive value of 95%, and negative predictive value of 78%. Integration of MRCA with CMR-MPI/LGE further improved CMR performance to 96% sensitivity, 89% specificity, positive predictive value of 92%, and negative predictive value of 94%, with a global accuracy of 93%. 
I n recent years, cardiovascular magnetic resonance (CMR) myocardial perfusion imaging (MPI) has evolved into a robust technique and provides state-of-the-art assessment of myocardial ischemia in clinical routine. 1, 2 The high spatial and temporal resolution, absence of ionizing radiation and integration with scar imaging using late gadolinium enhancement (LGE) techniques are unequivocal advantages of the method. Magnetic resonance coronary angiography (MRCA) allows limited morphology evaluation of the coronary arteries that is not possible with CMR-MPI and LGE. [3] [4] [5] [6] [7] Therefore, MRCA could potentially be used as a complementary tool to improve CMR-MPI/LGE diagnostic performance in patients with suspected CAD. However, the vast majority of MRCA studies included patients with known CAD clinically referred for x-ray invasive coronary angiography (XA), which limits the evaluation of MRCA as an auxiliary tool. 1 Furthermore, the potential additive value of MRCA integration into a CMR protocol, including stressrest MPI and LGE, is not well established. 8, 9 All previous studies evaluated MRCA performance against diameter of stenosis as assessed by XA, using either quantitative coronary angiography (QCA) or visual estimation. The use of these anatomic standards as reference may overemphasize the value of this morphological test when integrated into a comprehensive protocol. Evidence shows that patients should be managed according to the functional significance of the lesions and this should be the standard against which diagnostic tests should be compared. 10 The aim of this study was to evaluate the potential additive value of integration of a 1.5T whole-heart MRCA sequence into a CMR-MPI protocol for the diagnosis of functionally significant CAD, as assessed by XA and fractional flow reserve (FFR), in the clinical setting of a tertiary cardiology center of a nonacademic hospital.
Methods Population
We prospectively screened 176 consecutive patients with suspected CAD referred to the cardiology outpatient clinic from February 2010 to November 2011. Inclusion criteria were: age >40 years and symptoms compatible with CAD and at least 1 of the following: ≥2 risk factors or positive/inconclusive treadmill test. Exclusion criteria included unstable clinical status, known CAD, valvular heart disease, atrial fibrillation/irregular heart rhythm, creatinine clearance ≤60 mL/ min and standard contraindications to CMR, contrast media, and adenosine. Figure 1 summarizes the study flow and reasons for exclusions. Forty-three patients completed the entire study protocol and constituted the population sample of the study.
Study Design
Patients were scheduled for a CMR scan in the week before XA and were instructed to refrain from smoking, coffee, tea, aminophylline, β-blockers, calcium-channel antagonists and nitrates for 24 hours before both procedures. At the time of XA, FFR was measured in all major patent coronary arteries with intermediate diameter stenoses (50% to 90%) as assessed by QCA.
CMR Protocol
CMR-MPI/LGE protocol followed established standards 11 on a 1.5T Siemens Symphony TIM scanner (Siemens, Erlangen, Germany) using a 12-channel receiver coil as previously described, 12 with an additional 3-dimensional navigator-corrected steady-state free precession whole-heart MRCA performed between the rest perfusion scan and the LGE acquisition. Figure 2 represents the simplified scheme of the CMR protocol.
For perfusion imaging, 3 short-axis slices (basal, midventricular, and apical) were acquired under maximal hyperemia achieved with 140 µg·kg −1 ·min −1 IV adenosine infusion, during the first pass of a bolus of 0.07 mmol·kg −1 of gadobutrol (Gadovist, Bayer HealthCare Pharmaceuticals, Berlin, Germany) injected at 4 mL·s −1 through a dedicated right antecubital vein. A gradient-echo pulse sequence with a single saturation prepulse per cardiac cycle shared over the 3 slices was used. In patients with significant heart rate variability or in whom heart rate was still >80 bpm 3 minutes after adenosine discontinuation, 5 mg of IV metoprolol were administered. 13 Longand short-axis cine images were obtained using a steady-state free precession breath-hold sequence for volumetric and functional analysis and 10 minutes after the first gadolinium injection; perfusion imaging was repeated at rest, using the same parameters described Figure 1 . Study flow-chart and reasons for exclusions. CAD indicates coronary artery disease; CI, confidence interval; CMR, cardiac magnetic resonance; FFR, fractional flow reserve; and MRCA, magnetic resonance coronary angiography.
for the stress. Immediately afterwards, additional gadolinium (0.06 mmol·kg −1 , to achieve a total of 0.2 mmol·kg −1 ) was administered. A 4-chamber cine with 50 phases per cardiac cycle was then used to determine the timing and duration of the individual cardiac rest period visually.
14 MRCA number of segments per heart cycle and acquisition window were planned aiming to acquire images during the heart's quietest period (usually diastase). Trigger delay and temporal resolution were adjusted to each patient. Sublingual nitroglycerine (0.5 mg) was administered and volumetric whole-heart MRCA transaxial images acquired using a steady-state free precession free-breathing pulse sequence (TR [repetition time]/TE [echo time], minimal/minimal; flip angle, 90º; slice thickness 1.0 mm) with fat suppression and T2 preparation prepulse, as proposed by Weber et al. 15 Breathing motion was compensated using a craniocaudal navigator technique (search window: 90 mm; acceptable gating window: 5 mm at end expiration). Isotropic spatial resolution (1.0×1.0×1.0 mm) was achieved. MRCA acquisition was terminated if the scan length was expected to exceed 25 minutes. After the MRCA acquisition, a 2-dimensional phase-sensitive inversionrecovery breath-hold sequence was used for LGE imaging. This acquisition was performed for at least 10 minutes (but no longer than 30 minutes) after the last administration of gadolinium. The same projections performed for functional analysis were used.
CMR Analysis
CMR images were visually evaluated on commercially available software by 2 independent readers (level III SCMR) fully blinded to the results of XA and to the other components of the CMR examination. In cases of disagreement between observers, consensus reading was performed.
Myocardial Perfusion/Late Gadolinium Enhancement
Perfusion defects were defined as subendocardial or transmural visually dark myocardial areas when compared with remote healthy myocardium, persisting for at least 10 frames (Figure 3 ). In case of circumferential perfusion defects, the epi-to endocardial wash-in dynamic of the contrast was also evaluated. The stress and rest perfusion scans were viewed simultaneously, and areas of hypoperfusion were assigned to the ventricular segments, using the standard American College of Cardiology/American Heart Association 17-segment model, excluding the apex. 16 Each of the 16 segments was classified using a 4-point scoring system: from normal/no defect to transmural-defect. Perfusion defects were then classified as caused by ischemia or scar-integrating the information obtained from functional analysis, Four cases illustrating CMR-MPI, MRCA, and XA angiographic findings in patients with and without functionally significant coronary artery disease. A, In a 62-year-old woman with diabetes mellitus, hypertension, dyslipidemia, and typical angina, both CMR-MPI and MRCA were reported normal; XA confirmed normal epicardial coronary arteries. B, In this 49-year-old dyslipidemic, hypertensive, ex-smoker, man with atypical angina, CMR-MPI showed a dark area of reversible ischemia in the mid and distal septal wall (arrows); a significant stenosis was detected on proximal and mid left descending artery during MRCA and its subocclusive status confirmed in XA (arrowhead). C, A subtle subendocardial dark area was noted on CMR-MPI (arrows) of this 75-year-old man with atypical chest-pain and no risk-factors, and interpreted as a possible artifact; MRCA correctly identified significant stenoses on proximal and mid left descending artery (arrowheads), confirmed on XA (FFR=0.92 and 0.69, respectively). D, In this 60-year-old, ex-smoker man with dyslipidemia and atypical chest-pain, CMR-MPI was reported normal, whereas MRCA depicted an obstructive stenosis in the mid segment of the right coronary artery, confirmed as occlusive on XA (arrowheads). CAD indicates coronary artery disease; CMR, cardiac magnetic resonance; FFR, fractional flow reserve; MPI, myocardial perfusion imaging; MRCA, magnetic resonance coronary angiography; and XA, x-ray coronary angiography.
by guest on June 19, 2017 http://circimaging.ahajournals.org/ Downloaded from perfusion, and LGE imaging. Regional wall motion or scar alone was not regarded as a sign of ischemia/CAD. Only areas with ischemia on perfusion imaging were regarded as positive (patients with scar but no additional ischemia were classified as negatives). Image quality and degree of confidence were classified independently using 4-class scales: from poor to excellent and from very unconfident to very confident, respectively.
MRCA
MRCA volumetric images were reconstructed, anonymized, and transferred to a postprocessing workstation (Aquarius WorkStation, TeraRecon Inc, San Mateo, CA). Axial-source images, multiplanar reformations, and thin-slab maximum intensity projections (1-5 mm) were used for detection of stenoses, depicted as local signal attenuation (Figure 3 ), according to the 17-segment modified AHA classification. 17 Each segment was graded as follows: 0: normal; 1: nonsignificant stenosis (<50%); 2: stenosis ≥50%; 3: uninterpretable (significant stenoses are impossible to exclude but not definitively present); and 4: not visible. The image quality of whole-heart MRCA was visually evaluated using the following scale: 0: poor (coronary vessel barely evident or noisy image); 1: moderate (coronary vessel visible but low diagnostic confidence); 2: good (coronary artery adequately visualized and diagnostic quality image); and 3: excellent (coronary artery clearly depicted with sharply defined borders). 3 All coronary arteries were included for the evaluation regardless of image quality to avoid overestimation of the diagnostic accuracy. Degree of confidence was classified as described for CMR-MPI. For the MRCA nondichotomic receiver operator characteristics curve analysis, the 2 observers visually graded the likelihood of coronary artery stenoses according to the following scale: 0: absent; 1: probably absent; 2: possibly present; 3: probably present; and 4: definitely present. Results for the 2 readers were averaged. ) over 3 to 6 minutes. Arteries were recorded as having significant flowlimiting disease if they had stenoses ≥90% (≥50% in left main stem), or had an FFR value ≤0.80 in vessels >2 mm. This was defined as the reference standard against which CMR was compared.
X-ray Coronary Angiography and FFR Assessment

Assignment of CMR Perfusion Segments to the Corresponding Vascular Territory
For vessel-based analysis, each of the 16 myocardial segments was assigned to 1 of the 3 main vessels (right coronary artery, left anterior descending artery, and circumflex artery). A total of 129 vessels (43 patients ×3) were used in this analysis. Left main stenoses were managed as simultaneous stenoses in left anterior descending and circumflex arteries. To ensure correct association of the segments with the vascular territory, angiographic visualization of vessel dominance and branch distribution was used. 16 
Statistical Analysis
Functionally Significant CAD was defined on patient-and vessel-basis.
The individual diagnostic performances of CMR-MPI/LGE and MRCA for the detection of functionally significant CAD were compared against XA+FFR as the reference standard. Sensitivity, specificity, positive predictive value, negative predictive value, and overall accuracy for each component of the CMR protocol and for the different integrative approaches were estimated having XA+FFR as a gold standard. A specific subanalysis was also performed for patients with intermediate pretest probability. Ninety-five percent confidence intervals were calculated based on the binominal distribution.
All continuous variables were expressed as mean±SD or median and interquartile range, whereas categorical variables were expressed as percentages. The McNemar test was used to calculate differences among proportions (sensitivity, specificity, and accuracy) obtained from paired observations. Within patient correlations between observations in per-vessel analysis were not taken into consideration because of the exploratory nature of the study. Cohen's κ statistic was used to assess intermodality and intra/interobserver agreements. The area under the receiver operator characteristic curve (AUC) was calculated and compared for all diagnostic-testing strategies using the method described by DeLong et al. 18 Statistical analyses were performed using MedCalc for Windows, version 12.3.0.0 (MedCalc Software, Mariakerke, Belgium). A P value <0.05 was considered statistically significant.
Ethics
The study protocol was approved by the local research ethics committee and complies with the declaration of Helsinki. Written informed consent was obtained from all participants.
Results
The final population consisted of 43 individuals (61±8.3 years, 65% males) with an intermediate (n=26) or high-pretest (n=17) probability for CAD according to the modified Diamond-Forrester score. 19 Patient characteristics are summarized in Table 1 . CMR scans were performed within 8±7.5 days (median of 6 days; interquartile range, 5-7 days) before XA. Mean examination duration was 54.8±9.62 minutes, ranging from 38 to 73 minutes. Patients' heart rate, blood pressure, and duration of the different CMR modules are shown in Table 2 .
Perfusion and Late Gadolinium Enhancement
All CMR-MPI scans were evaluated for visual diagnostic purposes and included in an intention-to-diagnose analysis. Two patients (4%) had poor quality images because of inadequate ECG-triggering. Image quality was moderate in 8 (19%), good in 25 (58%), and excellent in 8 (19%) patients. Readers felt unconfident in 3 cases (7%), confident in 27 (63%), and very confident in 13 (30%).
LGE scanning was performed 17.9±4.69 minutes (10-28) after the last perfusion sequence. Myocardial fibrosis/scar was detected in 12 patients (9 of which had an ischemic pattern). Interobserver per-patient agreement for the identification of abnormal perfusion produced a κ of 0.72 (95% confidence interval [CI], 0.52-0.93; substantial agreement).
MR Coronary Angiography
Whole-heart MRCA was successfully completed in the 43 patients comprising the final sample, with a mean planning time of 6.2±2.58 minutes and a mean effective scan time of 11.7±3.77 minutes (5.5-22) . Inclusion of the MRCA sequence into the CMR-MPI/LGE protocol was associated with a mean increase of 7.9±4.69 minutes (0-17.7) in examination duration. The mean heart rate during MRCA was 65±5.8 bpm and mean navigator efficiency was 32±7.7%. MRCA was performed during diastole in 40 patients (93%) and during systole in 3 (7%). The mean acquisition window was of 126±48 ms.
Eight patients (19%) yielded nondiagnostic images and diagnostic confidence was, therefore, classified as very unconfident. Image quality was moderate in 14 patients (33%), good in 17 (40%), and excellent in 4 (9%). On those, readers were unconfident in 8 cases (19%), confident in 25 (58%), and very confident in 2 (5%).
Sixteen patients had at least 1 stenosis>50% based on MRCA, 7 had no significant stenosis, and in 20 patients, MRCA was inconclusive (classified positive for CAD in the dichotomic evaluation of isolated MRCA). The κ value for the binary interobserver judgment in per-patient analysis was 0.49 (95% CI, 0.19-0.79; moderate agreement).
X-ray Coronary Angiography and FFR Results
Twenty-eight patients had some degree of coronary lumen stenosis on visual analysis and were evaluated using QCA: of those, 27 had stenosis ≥50%, including 16 with total/subtotal occlusions and 2 with left main disease. Nine patients with intermediate stenosis in vessels >2 mm were evaluated using FFR invasive assessment. Using this approach, a total of 24 patients were classified as having functionally significant CAD: single-vessel disease was seen in 11 patients; 8 had double-vessel disease; and 5 had triple-vessel disease.
Patient-and Vessel-Based Analysis
Diagnostic patient-and vessel-based performances are summarized in Table 3 . Figure 5 represents the receiver operator characteristics curve analysis of each component of the CMR protocol and different integrative approaches for detection of functionally significant CAD.
CMR-MPI
Of the 20 patients with a perfusion defect suggestive of ischemia on their CMR-MPI/LGE scan, 19 (95%) had significant CAD in at least 1 coronary artery (1 false-positive); of the 23 patients with no ischemia detected on CMR-MPI/LGE, 5 were false-negatives (2 of those patients were the ones with reported insufficient image quality because of ECG-triggering failure). CMR-MPI/LGE had a sensitivity of 79/71%, specificity of 95/97%, and global accuracy of 86/88% in patient-and vessel-based analysis, respectively. Excluding the 2 poor quality scans, sensitivity would be 86/77%, specificity 95/96%, and global accuracy 90/90%, respectively.
MRCA
The AUC for MRCA was 0.89 (95% CI, 0.75-0.96) in patientbased and 0.83 (95% CI, 0.76-0.89) in vessel-based analysis. Spearman's rank correlation coefficient between the 2 readers was 0.46. Using a dichotomic classification and having nonevaluable segments as positives, isolated MRCA had a sensitivity of 96/90%, specificity of 68/63%, and global accuracy of 83/73% in patient-and vessel-based analysis, respectively. In per-vessel analysis, MRCA accuracy was significantly inferior to CMR-MPI/LGE (88% versus 72%; P=0.004). If nonevaluable/not-visible vessels (n=28) were excluded from analysis, isolated MRCA would have a global accuracy of 89/83%, with a sensitivity of 95/90% and specificity of 81/80%, in perpatient and per-vessel analysis, respectively.
Integrated Analysis
Integration of anatomic and functional data from MRCA and CMR-MPI/LGE slightly increased overall CMR accuracy for detection of functionally significant CAD in the tested population. In per-patient analysis, the best performing protocol (C) followed CMR-MPI/LGE results in all cases but when a definite significant stenosis was depicted by MRCA ( Figure 4) 22) , and all the other integrative approaches. The additive value of this protocol is represented by a nonsignificant 17% increase in sensitivity (79% versus 96%; P=0.13) and an irrelevant 5% decrease in specificity (95% versus 90%; P=1.0) when compared with isolated CMR-MPI/LGE. This nonsignificant benefit seems particularly evident in the subgroup of patients with intermediate pretest probability, in which per-patient performance increased from a sensitivity of 64% to 91% (P=0.25), whereas keeping the excellent specificity (100%). Global accuracy improved from 85 to 96% (P=0.25).
In 
Discussion
The main finding of our study is that in symptomatic patients with intermediate/high pretest probability, integration of MRCA into a CMR-MPI/LGE stress-rest protocol nonsignificantly improved per-patient diagnostic performance for detection of functionally significant CAD, at a cost of prolonged scanning times. This small improvement in diagnostic performance was obtained from a per-vessel significant increase in sensitivity and an associated decreased specificity.
Differently from previous studies, which used QCA or visual assessment of the degree of stenosis as the reference standard for CAD, we used XA with FFR assessment. This approach avoids overestimation of the incremental value that MRCA can bring into a comprehensive CMR protocol if a purely anatomic standard is used for reference and follows evidence showing that patients should be guided by the physiological importance of a stenosis rather than by luminal assessment. The entire comprehensive CMR scan, including functional and volumetric assessment, stress and rest perfusion analysis, coronary angiography, and scar imaging was completed in <1 hour, on average. This duration is inferior to previously published protocols 8, 9 and was achieved by acquiring all the cine images between the 2 perfusions scans and performing MRCA between the last perfusion and LGE imaging. This approach allowed the use of medication (nitrates and β-blockers) aiming to improve MRCA quality without influencing perfusion results 8 and reduced scan time, as a significant part of the MRCA scanning is planned, prepared, and acquired in the 10-minute gap existing between the last perfusion acquisition and the beginning of LGE scanning. Nevertheless, MRCA inclusion into a CMR-MPI/LGE protocol represented a significant prolongation of the scanning time (14% increase), and in a few patients, the entire scan exceeded 70 minutes. Furthermore, some patients were excluded from the study because of irregular breathing patterns and extremely low gating efficiency that would prolong MRCA scan to >25 minutes. Besides the effective acquisition time, sequence planning is also time-consuming and represented 35% of the total time required for the MRCA component in our study. Additionally, MRCA analysis requires extratime (15-20 minutes on average) of dedicated postprocessing and image interpretation. Therefore, the interesting concept of anatomic and functional integration into a single radiation-free test has to be tempered by the limited additional information obtained and the extra scanning time needed. Scan time availability is usually an important issue in busy CMR clinical lists and other available tests might be considered in those rare cases in which noninvasive morphological evaluation is considered determinant. Based on our data, MRCA integration does not seem to be routinely justified in clinical stress-rest 1.5T CMR-MPI/ LGE protocols aiming to detect significant CAD because its additive value is still limited. Nevertheless, it is interesting to observe that anatomic and functional integration further improved CMR ability to detect functionally significant CAD and represented 3/43 (7%) of additional correct diagnosis in our study. Together with the recently described prognostic value of MRCA, 20 this finding should prompt further research aiming to improve robustness of the technique as well as simplification/automation of procedures, namely in sequence/scanning preparation, which are still cumbersome and time-consuming.
In our study, MRCA had lower interobserver agreement than CMR-MPI. Furthermore, 19% of MRCA scans had poor image quality, and a large number of coronary segments were found to be unavailable, significantly limiting MRCA potential as an auxiliary tool for noninvasive detection or exclusion of CAD. The use of a tight-fitting abdominal belt to suppress the motion of the diaphragm in relation to breathing has been described to reduce imaging artifacts and scanning time and may result in increased performance. 7, 21 However, in clinical practice, most CMR studies are not directed toward isolated visualization of coronary arteries, but are rather combined with CMR-MPI/LGE; in these combined approaches, we may expect MRCA performance to be less efficient as reported in MRCA-centered studies. 22 Two previous studies tested 1.5T-MRCA value in a comprehensive protocol; in both, MRCA performed significantly worse than CMR-MPI/ LGE and did not increase global diagnostic accuracy. 8, 9 In our intermediate/high risk population, MRCA was also inferior to CMR-MPI/LGE, but a small positive impact of integration, mainly restricted to an increased sensitivity, was noticed. This was especially important in cases of poor ECG-triggering in the stress perfusion scan, which represented 2 of the 4 false-negatives correctly depicted by MRCA. Inclusion of all patients despite image quality may justify differences from previous studies.
Based on the large published trials, CMR-MPI weakness is expected to reside in its specificity, 23 possibly because of inherent difficulties in distinguishing multivessel disease from microvascular disease patterns. In our study, MRCA potential ability to increase CMR specificity by excluding 3-vessel disease in the differential diagnosis with microvascular disease 7 could not be tested as all the multivessel disease diagnoses based on the CMR-MPI/LGE component were true-positives and no patterns of microvascular disease were reported.
Study Limitations
In this single-center study, only patients without known CAD and with an intermediate/high-pretest probability were included. A non-negligible percentage of patients had exclusion criteria and a significant proportion of eligible patients were not included because of scanner-time limitations. Furthermore, MRCA images could not be acquired in ≈8% of patients undergoing CMR; this was not taken into consideration for the diagnostic performance analysis.
New available technology, namely the use of higher field scanners and higher number of channels coils may outperform the method described. Contrast-enhanced MRCA at 3.0-T has improved contrast-to-noise ratio, allows faster scanning and seems to superiorly compare with noncontrast-enhanced 1.5T-MRCA. [24] [25] [26] However, this has never been validated in a multicenter trial and its additive value as part of a comprehensive CMR protocol was never tested.
The limited number of patients of our study does not allow definitive conclusions on the added value of MRCA in this context. However, our data reveals that integration of anatomic and functional information can be achieved using CMR in the clinical setting and that this approach might lead to improved performance in detecting functionally significant CAD. Larger prospective studies testing are, therefore, warranted.
Conclusions
In this intermediate/high-pretest population, integration of noncontrast-enhanced whole-heart MRCA nonsignificantly improved per-patient diagnostic accuracy of a comprehensive 1.5-T stress-rest CMR-MPI/LGE protocol at a cost of longer scanning times.
CLINICAL PERSPECTIVE
In this study, magnetic resonance coronary angiography (MRCA) was evaluated as an additive tool to a stress-rest adenosine perfusion cardiac magnetic resonance (CMR) protocol, including functional analysis and late gadolinium enhancement. Despite the limitations associated with the technique, integration of MRCA did not significantly improve the performance of CMR for detection of functionally significant coronary artery disease, as assessed by invasive coronary angiography and fractional flow reserve. Addition of MRCA was associated with a significant scan time prolongation. Of note, the study was conducted with standard and widely available software, using regular slots of a CMR clinical list of a nonacademic tertiary hospital, thus reflecting what may be achieved in real-world practice. Although this pilot study was underpowered to demonstrate incremental value of MRCA over stress CMR techniques, our results suggest that routine addition of MRCA to stress CMR may not be an effective strategy in the investigation of coronary artery disease. Further research is warranted to determine if the combined strategy of stress CMR and MRCA may be useful in selected patients. Likelihood of significant CAD (≥50% stenosis) as graded by the 2 readers: 0-absent; 1-probably absent; 2-possibly present; 3-probably present; and 4-definitely present.
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